Washington DC could see long-delayed start to recreational cannabis sales, new medical opportunities

Chart showing the growth in number of patients in the DC medical marijuana market.

Washington DC’s long-stalled recreational cannabis market could get a new lease on life now that Democrats control both chambers of Congress, a development that could generate more than $200 million in annual sales for local marijuana retailers in a few years.

At the same time, the District’s existing medical cannabis companies have gotten a shot in the arm now that a new regulatory agency oversees the industry.

The new regulator – the District’s Alcoholic Beverage Regulatory Agency (ABRA) – has taken steps to boost medical marijuana patient counts and make it easier for companies to operate.

The ABRA also would likely play a key part in rolling out a new recreational program.

Voters approved recreational cannabis seven years ago, but Congressional Republicans blocked the program’s launch.

With Democrats now in control of Congress, recreational sales could begin in roughly one year, one local industry executive predicted.

“I think it’s very possible that we could see sales by the end of 2021,” said Adam Goers, vice president of corporate affairs at Columbia Care, a New York-based multistate operator with a cultivation site in the District, plus a dispensary that operates as Capital City Care.

“The